Fatal intracardiac and pulmonary arterial thromboembolic damage following ABO-incompatible living donor liver transplantation for autoimmune hepatitis: A case report.
Won Kyu ChoiJunghan KimHo Joong ChoiSang Hyun HongMin-Suk ChaePublished in: Medicine (2021)
In patients with autoimmune hepatitis, risk factors for thromboembolism should be rigorously controlled during the peak period of reactive thrombocytosis after ABOi LDLT with splenectomy.